These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Double filtration and immunoadsorption plasmapheresis in Guillain-Barré syndrome]. Kuwabara S, Nakajima M, Moroo I, Hirayama K. Rinsho Shinkeigaku; 1996 Feb; 36(2):289-92. PubMed ID: 8752682 [Abstract] [Full Text] [Related]
5. Factors influencing outcome in Guillain-Barré Syndrome: comparison of plasma adsorption against other treatments. Seta T, Nagayama H, Katsura K, Hamamoto M, Araki T, Yokochi M, Utsumi K, Katayama Y. Clin Neurol Neurosurg; 2005 Oct; 107(6):491-6. PubMed ID: 16202823 [Abstract] [Full Text] [Related]
6. [Removal ability of anti-ganglioside antibodies in immunoadsorption using a modified tryptophan-immobilized column]. Tagawa Y, Yuki N, Hirata K. Rinsho Shinkeigaku; 1997 Oct; 37(10):863-7. PubMed ID: 9490893 [Abstract] [Full Text] [Related]
9. Comparing the autoantibody levels and clinical efficacy of double filtration plasmapheresis, immunoadsorption, and intravenous immunoglobulin for the treatment of late-onset myasthenia gravis. Liu JF, Wang WX, Xue J, Zhao CB, You HZ, Lu JH, Gu Y. Ther Apher Dial; 2010 Apr; 14(2):153-60. PubMed ID: 20438536 [Abstract] [Full Text] [Related]
11. Therapeutic plasma exchange in patients with neurologic diseases: retrospective multicenter study. Kaynar L, Altuntas F, Aydogdu I, Turgut B, Kocyigit I, Hacioglu SK, Ismailogullari S, Turgut N, Erkurt MA, Sari I, Oztekin M, Solmaz M, Eser B, Ersoy AO, Unal A, Cetin M. Transfus Apher Sci; 2008 Apr; 38(2):109-15. PubMed ID: 18331814 [Abstract] [Full Text] [Related]